Quanxin Bio-B (02509): QX001S Ustekinumab Injection Receives NDA and Supplemental Approval for Crohn's Disease in China
May 21, 2026 20:44
CST Updated
21:02
Qyuns
Developer of Biologics for Autoimmune and Allergic Diseases